0001477932-24-001618.txt : 20240329 0001477932-24-001618.hdr.sgml : 20240329 20240329163013 ACCESSION NUMBER: 0001477932-24-001618 CONFORMED SUBMISSION TYPE: NT 10-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240329 DATE AS OF CHANGE: 20240329 EFFECTIVENESS DATE: 20240329 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ASP Isotopes Inc. CENTRAL INDEX KEY: 0001921865 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS CHEMICAL PRODUCTS [2890] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 872618235 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: NT 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41555 FILM NUMBER: 24804422 BUSINESS ADDRESS: STREET 1: 1101 PENNSYLVANIA AVENUE NW STREET 2: SUITE 300 CITY: WASHINGTON STATE: DC ZIP: 20004 BUSINESS PHONE: 202-756-2245 MAIL ADDRESS: STREET 1: 1101 PENNSYLVANIA AVENUE NW STREET 2: SUITE 300 CITY: WASHINGTON STATE: DC ZIP: 20004 NT 10-K 1 aspi_nt10k.htm NT 10-K aspi_nt10k.htm

 

 

 

 OMB APPROVAL

 

 

OMB Number: 3235-0058

 

 UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Expires: April 30, 2025

Estimated average burden

 

Washington, D.C. 20549

hours per response.......2.50

 

 

 

 

FORM 12b-25

 SEC FILE NUMBER

 

001-41555

 

 

 

 

 

 CUSIP NUMBER

 

 NOTIFICATION OF LATE FILING

00218A105

 

(Check one):

☒

 Form 10-K

☐

 Form 20-F

☐

 Form 11-K

☐

 Form 10-Q

☐

 Form 10-D

☐

 Form N-SAR

☐

 Form N-CSR

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For Period Ended:  December 31, 2023

 

 

 

 

 

 

☐

 Transition Report on Form 10-K

 

 

 

 

 

 

☐

 Transition Report on Form 20-F

 

 

 

 

 

 

☐

 Transition Report on Form 11-K

 

 

 

 

 

 

☐

 Transition Report on Form 10-Q

 

 

 

 

 

 

☐

 Transition Report on Form N-SAR

 

 

 

 

 

 

For the Transition Period Ended: __________________________________________

 

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

 

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

 

PART I — REGISTRANT INFORMATION

 

ASP Isotopes Inc.

Full Name of Registrant

 

 

Former Name if Applicable

 

1101 Pennsylvania Avenue NW, Suite 300

Address of Principal Executive Office (Street and Number)

 

Washington, DC 20004

City, State and Zip Code

 

 

 

 

PART II — RULES 12b-25(b) AND (c)

 

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

 

☒

(a)

The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense

 

 

(b)

The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and

 

 

(c)

The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

 

PART III – NARRATIVE

 

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

 

(Attach extra Sheets if Needed)

 

The Registrant could not complete the filing of its Annual Report on Form 10-K for the year ended December 31, 2023, due to a delay in obtaining and compiling information required to be included in its Form 10-K, which delay could not be eliminated by the Registrant without unreasonable effort and expense. In accordance with Rule 12b-25 of the Securities Exchange Act of 1934, the Registrant will file its Form 10-K no later than the fifteenth calendar day following the prescribed due date.

 

PART IV — OTHER INFORMATION

 

(1)

Name and telephone number of person to contact in regard to this notification

 

Paul Mann

 

(202)

 

756-2245

(Name)

 

(Area Code)

 

(Telephone Number)

 

(2)

Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). Yes ☒      No ☐

 

 

(3)

Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? Yes ☐      No ☒

 

 

 

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

 

 
2

 

 

ASP Isotopes Inc.

(Name of Registrant as Specified in Charter)

 

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: March 29, 2024

By:

/s/ Paul Mann

 

 

 

Paul Mann

 

 

 

Chief Executive Officer

 

 

 
3